CAM
NEOS

Cormorant Asset Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Cormorant Asset Management’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-50,613
Closed -$369K – 71
2017
Q2 		$369K Hold
50,613
– – 0.06% 66
2017
Q1 		$364K Hold
50,613
– – 0.05% 71
2016
Q4 		$296K Hold
50,613
– – 0.04% 73
2016
Q3 		$333K Hold
50,613
– – 0.04% 77
2016
Q2 		$470K Buy
50,613
+613
+1% +$5.85K 0.07% 76
2016
Q1 		$540K Hold
50,000
– – 0.08% 76
2015
Q4 		$716K Hold
50,000
– – 0.09% 74
2015
Q3 		$1.05M Buy
+50,000
New +$1.1M 0.17% 72

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cormorant Asset Management's NEOS Position: Q3 2017 in Review

Cormorant Asset Management sold out of Neos Therapeutics, Inc (NEOS) in Q3 2017, closing a stake of 50,613 shares — an estimated $369K sold.

Cormorant Asset Management first reported a position in NEOS in Q3 2015 and held it in 8 quarters. The position peaked at $1.05M in Q3 2015. 63 funds tracked by Wall St. Rank hold NEOS as of Q3 2017.

  • Cormorant Asset Management reported no remaining Neos Therapeutics, Inc position as of Q3 2017 after selling out during the quarter.
  • Cormorant Asset Management sold 50,613 Neos Therapeutics, Inc shares in Q3 2017, an estimated $369K.
  • Cormorant Asset Management first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 8 quarters.
  • Cormorant Asset Management's Neos Therapeutics, Inc position peaked at $1.05M in Q3 2015.
  • 63 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q3 2017.

Based on Cormorant Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.